NDC 67046-238

Gabapentin

Gabapentin

Gabapentin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Contract Pharmacy Services-pa. The primary component is Gabapentin.

Product ID67046-238_5a05a77b-ab0e-d3f8-e053-2a91aa0a906f
NDC67046-238
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-09-25
Marketing CategoryANDA / ANDA
Application NumberANDA202764
Labeler NameContract Pharmacy Services-PA
Substance NameGABAPENTIN
Active Ingredient Strength800 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 67046-238-14

14 TABLET in 1 BLISTER PACK (67046-238-14)
Marketing Start Date2017-09-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67046-238-20 [67046023820]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-15 [67046023815]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-28 [67046023828]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-21 [67046023821]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-07 [67046023807]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-14 [67046023814]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-60 [67046023860]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

NDC 67046-238-30 [67046023830]

Gabapentin TABLET
Marketing CategoryANDA
Application NumberANDA202764
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-25
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN800 mg/1

OpenFDA Data

SPL SET ID:5a05a77b-ab0d-d3f8-e053-2a91aa0a906f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310433
  • 310434
  • UPC Code
  • 0369097811129
  • 0369097812126
  • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.